In addition, claudin-1 overexpression results in greater susceptibility to and poorer recovery from DSS-induced colitis [46], making it unclear whether the increase in claudin-1 in our study is a beneficial change or a compensatory mechanism. This evidence concerns the gene CLDN1 and colitis.